- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 4.02M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 3.86M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 515.47K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.48M |
| Operating Cash Flow | Q1 2026 · Dec 31, 2025 | −$7.8M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.93M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $6.95M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $7.52M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $6.41M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $6.22M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $7.3M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.56M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.05M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.64M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $7.47M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.86M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.48 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$4.47 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.48 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$4.47 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.54M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.06M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $383.72K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.28M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.85M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.3M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.93M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.34M |